Cargando…
Anthraquinones as Inhibitors of SOS RAS-GEF Activity
Recent breakthroughs have reignited interest in RAS GEFs as direct therapeutic targets. To search for new inhibitors of SOS GEF activity, a repository of known/approved compounds (NIH-NACTS) and a library of new marine compounds (Biomar Microbial Technologies) were screened by means of in vitro RAS-...
Autores principales: | Fernández-Medarde, Alberto, Fuentes-Mateos, Rocío, García-Navas, Rósula, Juan, Andrea Olarte-San, Sánchez-López, José María, Fernández-Medarde, Antonio, Santos, Eugenio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8392861/ https://www.ncbi.nlm.nih.gov/pubmed/34439794 http://dx.doi.org/10.3390/biom11081128 |
Ejemplares similares
-
Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia
por: Gómez, Carmela, et al.
Publicado: (2022) -
Functional Specificity of the Members of the Sos Family of Ras-GEF Activators: Novel Role of Sos2 in Control of Epidermal Stem Cell Homeostasis
por: Baltanás, Fernando C., et al.
Publicado: (2021) -
Critical requirement of SOS1 RAS-GEF function for mitochondrial dynamics, metabolism, and redox homeostasis
por: García-Navas, Rósula, et al.
Publicado: (2021) -
Optimized Protocol for Isolation and Culture of Murine Neonatal Primary Lung Fibroblasts
por: Fuentes-Mateos, Rocío, et al.
Publicado: (2023) -
The CSN3 subunit of the COP9 signalosome interacts with the HD region of Sos1 regulating stability of this GEF protein
por: Zarich, Natasha, et al.
Publicado: (2019)